BILL ANALYSIS
HR4086
BULLISHAutism Family Caregivers Act of 2025
HR4086 (Autism Family Caregivers Act of 2025) carries an AI-assessed market impact score of 4/10 with a bullish outlook for investors. This legislation directly affects $AMN, $LH and $IQV. The primary sectors impacted are Healthcare. View the full bill text on Congress.gov.
4/10
Impact Score
bullish
Market Sentiment
3
Affected Stocks
1
Sectors Impacted
Key Takeaways for Investors
HR4086 establishes a new federal grant program for caregiver skills training for families of children with autism and developmental delays.
The bill creates a new funding stream for eligible entities providing evidence-based training, benefiting healthcare service providers and research organizations.
Bipartisan sponsorship (36 cosponsors) increases the bill's legislative momentum and chances of passage.
How HR4086 Affects the Market
This bill creates a new revenue opportunity for healthcare service providers and research organizations focused on developmental disabilities. Healthcare staffing companies like AMN Healthcare Services ($AMN) will see increased demand for skilled professionals. Contract research organizations such as Laboratory Corporation of America Holdings ($LH) and IQVIA Holdings Inc. ($IQV) are positioned to secure contracts for program evaluation and training development. The overall market for autism and developmental disability support services will expand due to this dedicated federal funding.
Bill Details
| Metric | Value |
|---|---|
| Bill Number | HR4086 |
| Impact Score | 4/10AI Adjustment: AI detected additional qualitative factors (+1) · Legislative Stage: Introduced · Cosponsor Momentum: 36 cosponsors — building momentum |
| Market Sentiment | bullish |
| Event Date | |
| Affected Sectors | Healthcare |
| Affected Stocks | $AMN, $LH, $IQV |
| Source | View on Congress.gov → |
Summary
The Autism Family Caregivers Act of 2025 establishes a grant program for evidence-based caregiver skills training for families of children with autism and developmental delays. This creates a new funding stream for organizations providing such services, benefiting healthcare providers and research entities. The bill has bipartisan support and is in the early stages of the legislative process.